Printer Friendly

Drug company buys antibody firm.

A small company that has been the leader in developing medical diagnostic tests using monoclonal antibodies has been purchased by a major drug company, Eli Lilly and Co. of Indianapolis, for more than $300 million. Hybritech, Inc., a San Diego firm that is one of the most financially successful of the specialized biotechnology companies, produces and markets diagnostic tests for a variety of conditions including colon and prostate cancer, infertility, allergies and pregnancy (SN: 5/7/83, p. 296). The company is also exploring the use of monoclonal antibodies in therepy against infectious diseases. The acquisition, still subject to Hybritech stockholder approval, moves Lilly into the rapidly growing diagnostic business and bolsters its research efforts toward using monoclonal antibodies to treat certain cancers. Monoclonal antibodies are very pure antibodies that bind to a single specific target.

Hybritech recently received a setback when its broad patent on a monoclonal antibody method, widely used in making diagnostic and medical monitoring tests, was ruled to be invalid by a federal district court in San Francisco. Hybritech announced that it plans to appeal that decision.
COPYRIGHT 1985 Science Service, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1985, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Eli Lilly and Co. buys Hybritech Inc.
Publication:Science News
Date:Oct 5, 1985
Previous Article:Cocaine use: disturbing signs.
Next Article:Panda pedigree: giant and lesser.

Related Articles
Lilly to sell or spin off medical-device business.
City gets option to buy 2 Broadway buildings.
County will bargain, not seize land.
KUWAIT - The Divided Zone.
Compounded drugs are dangerous concoctions, critics say.
Making the most of motions in limine: you can defeat five common defense arguments in medical negligence cases before trial even begins. Motions in...
The Whistleblower: Confessions of a Healthcare Hitman.
Citing Merck misconduct, jurors find for plaintiff in Vioxx retrial.
Drugs just a click away: online pharmacies can make dangerous drugs easy to get, but also can promote better health care. Should we regulate them?

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters